BIMI Holdings Inc.BIMI

Market cap
$21.92K
P/E ratio
Dec 31,
2011
Dec 31,
2013
Dec 31,
2014
Dec 31,
2015
Dec 31,
2016
Dec 31,
2017
Dec 31,
2018
Dec 31,
2019
Dec 31,
2020
Dec 31,
2021
Dec 31,
2022
NET LOSS------1,578,415-16,999,794-4,452,279-1,877,925-34,921,745-22,318,056
Depreciation and amortization588,278831,084844,6571998,189944,0121261,98356,041244,116223,561
Impairment loss of Goodwill---------265
Inventories impairment reserve---------93,88459,567
Allowance for doubtful accounts------1520,969146,977-53,6981
Amortization of discount of convertible promissory notes-------104,9752554,2923
Profit/Loss on disposal of discontinuing operations and subsidiaries----------529,320
Accounts receivable--------48,387---1,357,394
Advances to suppliers-----------490,168
Inventories-271,495132-2,074,453-2,746,175-1,055,168-106,440--5
Prepayments and other receivables-----------464,103
Operating lease-right of use assets-393,50329,792-238,756769,446909,360316,621-720,899-93,592-976,3721
Accounts payable, trade--------5-453,7386
Advances from customers-----------970,688
Operating lease liabilities--------45,520915,0041
Taxes payable-----------219,026
Other payables and accrued liabilities357,650-145,39471,11563,311457,2881510,499-1,925590,979-2,617,7651
Net cash used in operating activities from continuing operations-892,708-995,080-2,473,729159,832---1,094,441--1,275,725-10,255,206
Net cash provided by operating activities from discontinued operations--------970,351843,382--
Net cash used in operating activities2-----908,229-343,970-2,064,792-3,517,733-1,275,725-10,255,206
Disposal of Zhuoda----------924,740
Payment for the acquisition of Qiangsheng, Eurasia and Mingkang Hospitals---------3-
Payment for the acquisition of Phenix Bio Inc----------2
Deposit for the acquisition of Cogmer--------3-3,065,181-
Discontinued operations-Disposal of Zhuoda-----------27,117
Discontinue operations-held for sale of Zhongshan, qiangsheng, Eurasia and Mingkang----------311,277
Purchase of property, plant, and equipment38,68296,038218,744204,472191,375---258,961--
Net cash used in investing activities from continuing operations--921,993-341,6342-407,505--116,976-12,424,465-696,517-536,866
Net cash provided by investing activities from discontinued operations-------49,74112--
Net cash (used in) provided by investing activities-3,161,644------166,717-724,465-696,517-536,866
Issuance of common stocks------500,000---5
Net proceeds from issuance of convertible promissory notes--------534,2017-
Repayment of short-term loans----------49,882
Repayment of long-term loans----------486,442
Amount financed from (to) related parties--------148,700-478,1834
Net cash provided by financing activities from continuing operations--2,093,199248,251-45,160--1468
Net cash provided by financing activities from discontinued operations-------819,609---
Net cash provided by investing activities2----1211,2642468
EFFECT OF EXCHANGE RATE ON CASH----------85,681
(DECREASE) INCREASE IN CASH--------133,7085-2,272,795
Cash paid for income tax333,6157,94865,413---117-45,178444,6336,092
Cash paid for interest expense, net of capitalized interest-----353,745388,623-101,417163,883163,326
Issuance of shares of Common stock for the equity acquisition of Chongqing Guanzan Technology Co., Ltd.--------3--
Issuance of shares of Common stock for equity acquisition of Zhongshan Chaohu Hospital---------3-
Issuance of shares of Common stock for equity acquisition of Guoyitang Hospital-------3-4-
Issuance of shares of Common stock for equity acquisition of Zhuoda---------1-
Issuance of shares of Common stock for payment of improvements to offices---------696,896-
Goodwill recognized from equity acquisition of Guoyitang Hospital--------77-
Outstanding payment for equity acquisition of Zhongshan Chaohu Hospital---------5-
Common stock to be issued upon conversion of convertible promissory notes-960,000-2-------
Issuance of common share for equity acquisition of Mali Hospital---------5-